Related Experiment Video

Updated: Sep 12, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Cardiogenic Shock in Restrictive Cardiomyopathies: What We Know So Far

Ossama K Abou Hassan1, Ebere Chukwu1, John Schmittner1

  • 1Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center Temple, TX, US.

US Cardiology
|August 7, 2025
PubMed

Insights

Cardiogenic shock (CS) in restrictive cardiomyopathy (RCM) is a critical condition. Early diagnosis and management, including mechanical support and heart transplantation, improve survival for these complex patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) is a life-threatening state of systemic hypoperfusion due to cardiac dysfunction.
  • Restrictive cardiomyopathy (RCM) presents unique challenges in CS due to myocardial stiffness and impaired diastolic filling.
  • Unlike other CS etiologies, RCM often has preserved systolic function but elevated filling pressures.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and management of cardiogenic shock specifically in the context of restrictive cardiomyopathy.
  • To highlight the diagnostic complexities and therapeutic strategies for CS in RCM patients.

Main Methods:

  • Literature review focusing on restrictive cardiomyopathy and cardiogenic shock.
  • Analysis of diagnostic modalities including echocardiography and hemodynamic monitoring.
  • Evaluation of current and emerging treatment strategies.

Main Results:

  • CS in RCM is characterized by diastolic dysfunction and high filling pressures.
  • Accurate diagnosis requires advanced imaging and invasive monitoring.
  • Management involves optimizing hemodynamics, controlling arrhythmias, and considering mechanical support.

Conclusions:

  • Early recognition and tailored interventions are crucial for improving outcomes in CS due to RCM.
  • Heart transplantation is the definitive treatment for select RCM patients with CS.
  • Further research is needed to optimize CS management in this specific patient population.

Keywords:
Cardiogenic shockcardiac amyloidosishypertrophic cardiomyopathyrestrictive cardiomyopathyrestrictive physiology

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.2K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
56
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K